Citations

Showing 10 of 108152 citations.

ESTIMATION OF LONG‐TERM SURVIVAL WITH TAFASITAMAB + LENALIDOMIDE (LEN) IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)
Goswami, Budhaditya , Dey, Debarshi , Winderlich, Mark, Ambarkhane, Sumeet, Huang, Dan , Nowakowski, G. S., Salles, Gilles , Bagnardi, Vincenzo

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.90_2880 Get It

CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)
Herrera, Alex F. , Ansell, Stephen M. , Maddocks, Kami J. , Negievich, Yanina, Cruz, Hans G. , Wang, L., Wuerthner, Jens, Zinzani, Pier Luigi , Carlo‐Stella, Carmelo , Hamadani, Mehdi , Radford, John , Kline, Justin Paul , Savage, Kerry J. , Bartlett, Nancy L. , Caimi, Paolo F. , Collins, Graham P.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.75_2879 Get It

CALGB 50801 (ALLIANCE): PET ADAPTED THERAPY IN BULKY STAGE I/II CLASSIC HODGKIN LYMPHOMA (CHL)
LaCasce, Ann S. , Dockter, Travis , Ruppert, A. S., Kostakoglu, Lale , Bogart, Jeffrey A. , Cheson, Bruce D. , Wagner‐Johnston, Nina D. , Maddocks, Kami J. , Leonard, John P. , Schöder, Heiko , Hsi, Eric D. , Abramson, Jeremy S. , Bartlett, Nancy L.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.72_2879 Get It

TIME TO SECOND LINE BRUTON TYROSINE KINASE THERAPY AND AGE AT ITS INITIATION ARE STRONGLY ASSOCIATED WITH SUBSEQUENT OVERALL SURVIVAL IN PATIENTS WITH FIRST RELAPSE OF MANTLE CELL LYMPHOMA
Villa, Diego , Jiang, Alice , Crosbie, Nicola, Rule, Simon , McCulloch, Rory , Visco, Carlo , Kumar, Anita , Thanarajasingam, Gita , Bæch, Joachim , Kugathasan, Lakshmi , Lewis, David , Buege, Michael J. , Bond, David A. , Paludo, Jonas , Maurer, Matthew J. , El‐Galaly, Tarec Christoffer , Gerrie, Alina S.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.59_2880 Get It

AN OPEN‐LABEL TRIAL OF ORAL CA‐4948 AN IRAK4 INHIBITOR COMBINED WITH IBRUTINIB IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Ramchandren, Radhakrishnan , Nowakowski, Grzegorz S. , Lunning, M., Mead, Monica , Martinez, Elizabeth , Roemeling, R. von, Leslie, Lori A. , Joffe, Erel , Rosenthal, Allison , Tun, Han W. , Lunning, Matthew A.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.169_2880 Get It

BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN SUBJECTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) (TRIAL IN PROGRESS)
Yasenchak, Christopher A. , Ashraf, Khaleel K., Harwin, William N., Sims, Robert B., Nowakowski, Grzegorz S. , Bartlett, Nancy L.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.166_2880 Get It

FIRST‐MIND: A PHASE IB, OPEN‐LABEL, RANDOMIZED STUDY TO ASSESS SAFETY OF TAFASITAMAB OR TAFASITAMAB + LENALIDOMIDE IN ADDITION TO R‐CHOP IN PATIENTS WITH NEWLY DIAGNOSED DLBCL
Kopečková, Kateřina , Burgués, Juan Miguel Bergua, Pichler, P. , Klöpfer, Pia, Brackertz, Bettina, Lohrmann, E., Lahiry, Anirban , Shah, Neha , Brugger, Wolfram, Burke, John M. , Nowakowski, Grzegorz S. , Belada, David , André, Marc , Persona, Ernesto Pérez

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.149_2880 Get It

HEPATOSPLENIC T CELL LYMPHOMA: CLINICAL CHARACTERISTICS AND SURVIVAL
Moustafa, Magda, Hill, Brian T. , Jagadeesh, Deepa , Baidoun, Firas , Tun, Han W.

Mayo Clinic

Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available

10.1002/hon.134_2880 Get It